The consequence of matrix dysfunction on lung immunity and the microbiome in COPD

Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand

Source: Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD. Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

The microbiome in interstitial lung disease
Source: Lung Science Conference 2015
Year: 2015

The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012

Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Influence of bacteria from the COPD lung microbiome on cigarette smoke-induced pro-inflammatory responses of three-dimensional lung epithelial cell cultures
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018

The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019

The nature of inflammation and tissue damage in COPD
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004

Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia
Source: Eur Respir J 2003; 22: Suppl. 45, 416s
Year: 2003

The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015

Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021

COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012

Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003

Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020

The impact of bacterial colonisation on airway inflammation in stable COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012

The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018

IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021

Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020